Biomarker Analysis of Solid Cancers Such as Gastrointestinal Cancer
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Know the risks and potential benefits of clinical studies and talk to your health care provider before participating.
Read our disclaimer for details.
To prospectively collect ascites, pleural fluid, circulating tumor cells and derived primary cultures from metastatic cancer patients. The specimens will be analyzed using DNA/RNA/proteomic approaches.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
Child, Adult, Older Adult
Sexes Eligible for Study:
Accepts Healthy Volunteers:
1. Patients with histologically confirmed gastrointestinal, genitourinary, sarcoma, rare cancer
Patients with histologically confirmed gastrointestinal, genitourinary, sarcoma, rare cancer
Written informed consent
body fluid derived from cancer, available for drainage and collection
patients who do not give informed consent form for research use of biomaterials/biospecimens